Evidence map›Paper›PMID 31527246›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

Conversion of Sox2-dependent Merkel cell carcinoma to a differentiated neuron-like phenotype by T antigen inhibition.

Alexis Harold, Yutaka Amako, Junichi Hachisuka, Yulong Bai, Meng Yen Li, Linda Kubat, Jan Gravemeyer, Jonathan Franks, Julia R Gibbs, Hyun Jung Park and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Pharmacologic reversion of Merkel cell carcinoma via CBP/p300 inhibition.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. EmergingFrontiers in cell and developmental biology · 2025
    Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Merkel Cell Carcinoma Masquerading Clinically as a Cyst in a Young Patient.International medical case reports journal · 2024
    Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Alexis HaroldCancer Virology Program, Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA 15213.
Yutaka AmakoCancer Virology Program, Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA 15213.
Junichi HachisukaPittsburgh Center for Pain Research, University of Pittsburgh, Pittsburgh, PA 15213.
Yulong BaiDepartment of Human Genetics, University of Pittsburgh, Pittsburgh, PA 15260.
Meng Yen LiThe Tisch Cancer Institute, Black Family Stem Cell Institute, Department of Cell, Developmental, and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
Linda KubatTranslational Skin Cancer Research, Dermatology, German Cancer Consortium (DKTK), 45141 Essen, Germany.
Jan GravemeyerTranslational Skin Cancer Research, Dermatology, German Cancer Consortium (DKTK), 45141 Essen, Germany.
Jonathan FranksCenter for Biologic Imaging, University of Pittsburgh, Pittsburgh, PA 15261.
Julia R GibbsCancer Virology Program, Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA 15213.
Hyun Jung ParkDepartment of Human Genetics, University of Pittsburgh, Pittsburgh, PA 15260.
Elena EzhkovaThe Tisch Cancer Institute, Black Family Stem Cell Institute, Department of Cell, Developmental, and Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029.
Jürgen C BeckerTranslational Skin Cancer Research, Dermatology, German Cancer Consortium (DKTK), 45141 Essen, Germany.
Masahiro ShudaCancer Virology Program, Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA 15213; mas253@pitt.edu.ORCID 0000-0003-0595-2572
University of Pittsburgh · USDeutschen Konsortium für Translationale Krebsforschung · DEIcahn School of Medicine at Mount Sinai · USUPMC Hillman Cancer Center · US

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Jessie Nedrow · 1988 to 2026
$158.0M
Therapuetic Immune Targeting of EphA2 Expressed by Melanoma & Its Tumor-AssociateP50CA121973 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KIRKWOOD, JOHN MUNN · 2008 to 2018
$22.9M
Toward understanding the molecular mechanisms of Merkel cell fate determinationR01AR063724 · NIAMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI EZHKOVA, ELENA · 2012 to 2021
$4.2M
NCI NIH HHS P30 CA047904NCI NIH HHS P50 CA121973NIAMS NIH HHS R01 AR063724
6 · The paper itself

Abstract

Viral cancers show oncogene addiction to viral oncoproteins, which are required for survival and proliferation of the dedifferentiated cancer cell. Human Merkel cell carcinomas (MCCs) that harbor a clonally integrated Merkel cell polyomavirus (MCV) genome have low mutation burden and require viral T antigen expression for tumor growth. Here, we showed that MCV

Indexed as

PhenotypeAntigens, Viral, TumorCarcinoma, Merkel CellCell CycleCell LineageCell Line, TumorCell Transformation, ViralGene Knockdown TechniquesHumansKeratinocytesMerkel cell polyomavirusMerkel CellsNeuritesNeuronsPolyomavirus InfectionsSOXB1 Transcription FactorsAntigens, Viral, TumorSOX2 protein, humanSOXB1 Transcription FactorsAtoh1Merkel cell carcinomaMerkel cell polyomavirusphenotypic conversionSox2

Identifiers

PMID31527246
PMCPMC6778204
OpenAlexW2974456504

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.